Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population-based Randomized Study Of a Novel Breast Cancer Risk ALgorithm and Stratified Screening

NCT06060938 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT06060938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population-based Randomized Study Of a Novel Breast Cancer Risk ALgorithm and Stratified Screening
Lead sponsor
Herlev and Gentofte Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 2, 2024
Completion date
December 31, 2034
Enrollment
2,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer